Insider Purchases: Inside the Buy

Tag: CEO purchases

Illustration of Insperity as a turnaround stock, featuring a struggling office with payroll and benefits cost stress on one side and a confident executive reviewing HR recovery plans and improving charts on the other

🚀 Insperity (NSP): Why the CEO Just Bought Another $7.9M of This HR Stock

Insperity (NYSE: NSP) continues attracting major insider buying. CEO Paul Sarvadi has now purchased roughly $15.5 million of stock in less than three months, including a new $7.9 million purchase after shares rallied nearly 50%.


Read entire article

Tags: business services stocks, buy or sell NSP, ceo buys, ceo insider buy, CEO purchases, Deep value stocks, Deep Value-ish, Dividend stocks, DividendYield, featured-insiders, Follow the Money, FUNanc1al, FUNstock Index, HR stocks, HRTech, hub-insiders, human resources, Human resources outsourcing, Insider buying, insider purchases, insider trading, InsiderBuying, Insperity, NSP, NSP stock, NYSE NSP, Paul J. Sarvadi, Paul Sarvadi, Payroll stocks, PEO, PEO stocks, Recovery plays, risks buying NSP, ShortInterest, Small business services, small cap stocks, Smart Money Moves, Stock analysis, StockMarket2026, Stocks FUN, Turnaround stocks, Turnaround Watch, value stocks, ValueInvesting, why buy NSP
Illustration of a hospital patient monitor displaying a rising stock chart while a doctor injects a syringe labeled $11.9M, symbolizing Oscar Health’s turnaround driven by CEO insider buying and tech-driven healthcare innovation.

CEO Bets $11.9M: Is Oscar Health (OSCR) About to Shock the Market? 🚀

Oscar Health (OSCR) is no longer just a flashy disruptor—it’s aiming for profitability. With CEO Mark Bertolini buying $11.9M in stock and revenue projected to hit $19B in 2026, this could be one of the most compelling turnaround plays in healthcare.

Read entire article

Tags: ACA, ACA market, buy or sell OSCR, CEO confidence, CEO purchases, disruptive insurance, featured-insiders, fintech healthcare, FUNanc1al, Funanc1al Investing, growth stocks, health insurance stocks, healthcare tech, HealthInsuranceStocks, hub-insiders, insider buying, InsiderBuying, Investing2026, Mark Bertolini, MarkBertolini, multibagger stocks, Oscar Health, OscarHealth, OSCR, OSCR stock, risks buying OSCR, short squeeze stocks, turnaround stocks, undervalued stocks, why buy OSCR